Ipilimumab treatment associated with myasthenic crises and unfavorable disease course
Sign Up to like & getrecommendations! Published in 2018 at "Neurological Sciences"
DOI: 10.1007/s10072-018-3471-6
Abstract: Ipilimumab, a monoclonal antibody targeting the cytotoxic T lymphocyte antigen-4 is a treatment option for metastatic melanoma. This receptor serves as an inhibitor receptor on T lymphocytes and blockage of these results predisposition to autoimmune… read more here.
Keywords: treatment associated; crises unfavorable; treatment; myasthenic crises ... See more keywords